Arrowhead Pharmaceuticals, Inc. (LON:0HI3)

Arrowhead Pharmaceuticals Statistics

Total Valuation

LON:0HI3 has a market cap or net worth of GBP 2.88 billion. The enterprise value is 2.74 billion.

Market Cap	2.88B
Enterprise Value	2.74B

Important Dates

The last earnings date was Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	138.26M
Shares Outstanding	n/a
Shares Change (YoY)	+12.88%
Shares Change (QoQ)	+3.39%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	118.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.89
PB Ratio	7.60
P/TBV Ratio	7.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-25.31
EV / Sales	6.43
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-213.20

Financial Position

The company has a current ratio of 4.87, with a Debt / Equity ratio of 1.37.

Current Ratio	4.87
Quick Ratio	4.67
Debt / Equity	1.37
Debt / EBITDA	n/a
Debt / FCF	-40.48
Interest Coverage	-1.31

Financial Efficiency

Return on equity (ROE) is -37.11% and return on invested capital (ROIC) is -6.66%.

Return on Equity (ROE)	-37.11%
Return on Assets (ROA)	-5.96%
Return on Invested Capital (ROIC)	-6.66%
Return on Capital Employed (ROCE)	-9.10%
Revenue Per Employee	686,724
Profits Per Employee	-177,881
Employee Count	609
Asset Turnover	0.51
Inventory Turnover	n/a

Taxes

In the past 12 months, LON:0HI3 has paid 1.43 million in taxes.

Income Tax	1.43M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.22% in the last 52 weeks. The beta is 0.95, so LON:0HI3's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	+8.22%
50-Day Moving Average	18.34
200-Day Moving Average	17.62
Relative Strength Index (RSI)	79.14
Average Volume (20 Days)	2,271

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.99

Income Statement

In the last 12 months, LON:0HI3 had revenue of GBP 418.22 million and -108.33 million in losses. Loss per share was -0.83.

Revenue	418.22M
Gross Profit	418.22M
Operating Income	-78.80M
Pretax Income	-114.88M
Net Income	-108.33M
EBITDA	-62.33M
EBIT	-78.80M
Loss Per Share	-0.83

Balance Sheet

The company has 655.58 million in cash and 520.63 million in debt, giving a net cash position of 134.95 million.

Cash & Cash Equivalents	655.58M
Total Debt	520.63M
Net Cash	134.95M
Net Cash Per Share	n/a
Equity (Book Value)	379.41M
Book Value Per Share	2.76
Working Capital	549.17M

Cash Flow

In the last 12 months, operating cash flow was 15.94 million and capital expenditures -28.81 million, giving a free cash flow of -12.86 million.

Operating Cash Flow	15.94M
Capital Expenditures	-28.81M
Free Cash Flow	-12.86M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -18.84% and -25.90%.

Gross Margin	100.00%
Operating Margin	-18.84%
Pretax Margin	-27.47%
Profit Margin	-25.90%
EBITDA Margin	-14.90%
EBIT Margin	-18.84%
FCF Margin	n/a

Dividends & Yields

LON:0HI3 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.88%
Shareholder Yield	n/a
Earnings Yield	-3.76%
FCF Yield	-0.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HI3 has an Altman Z-Score of 0.9 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.9
Piotroski F-Score	4